The demonstration of true clinical proof-of-concept is a key value-creation step in the clinical development of a medicine.
The business model
The business model is based on discovering drugs and developing drug until phase 2a “Proof of concept" (PoC) and licensing them to the best possible commercial partner.
We are open
Melasma Pharmaceuticals are always open for Licensing deals / M&A / Strategic Collaboration / Development Veterinary drug – companion animals (Licensing deals)
Melasma Pharmaceuticals searching strategic Partnerships / Collaborations with other Biotech / Big Pharma / CRO in Dermatology therapeutic area.
We searching strategic investment with other Biotech / Venture Capital / Angel Investors